Your search history is turned on.
Date: May 30, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
Microsoft Word - Cytophage Press Release-Q1-Financials-Finals TSXV.CYTO Cytophage Reports Q1 Financials and Provides Business Update Winnipeg, May 30, 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (Cytophage or the Company), the only pub...
Date: May 27, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
Microsoft Word - Cytophage Press Release-NewBoardMember JohnSnisarenko-final (002) TSXV.CYTO Cytophage Strengthens Board of Directors Winnipeg, May 27, 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (Cytophage or the Company), the only pu...
Date: April 30, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
Microsoft Word - Cytophage Press Release-YearEnd-final TSXV.CYTO Cytophage Announces Fiscal Year End 2023 Results Winnipeg, April 30, 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (Cytophage or the Company), the only publicly traded phag...
Date: April 29, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
Microsoft Word - 1.B - 2023-12-31 - Cytophage - MD&A-V4 - CLEAN Managements Discussion and Analysis of Cytophage Technologies Inc. (Expressed in Canadian Dollars) For the year ended December 31, 2023 Effective Date: April 29, 2024 The following discussion is managements assessment and analysis of the results of operatio...
CYTOPHAGE TECHNOLOGIES INC. Consolidated Financial Statements For the Years Ended December 31, 2023 and 2022 (Expressed in Canadian Dollars) Page 1 Independent Auditors Report To the Shareholders of Cytophage Technologies Inc. Opinion We have audited the consolidated financial statements of Cytophage Technologies Inc. and its subsidiar...
Form 52-109F1-Annual Certifications-CEO & CFO (00390908.DOC;1) FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Steven Theriault, Chief Executive Officer of Cytophage Technologies Ltd., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, ...
Date: April 29, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
Q3 Results Managements discussion and analysis of the financial condition and results of operations of CYTOPHAGE TECHNOLOGIES LTD. (FORMERLY CUSPIS CAPITAL III LTD.) A Capital Pool Corporation For the years ended December 31, 2023 and 2022 ...
Annual Consolidated Financial Statements of CYTOPHAGE TECHNOLOGIES LTD. (FORMERLY CUSPIS CAPITAL III LTD.) A Capital Pool Corporation For the Years Ended December 31, 2023 and 2022 Page 1 Independent Auditors Report To the Shareholders of Cytophage Technologies Ltd. (forme...
VIA ELECTRONIC TRANSMISSION TO ALL APPLICABLE EXCHANGES AND COMMISSIONS: RE: CYTOPHAGE TECHNOLOGIES LTD. Confirmation of Notice of Record and Meeting Dates We are pleased to confirm that Notice of Record and Meeting Dates was sent to The Canadian Depository for Securities. We advise the following with respect to the upcoming Annual and Special Meeting of Securi...